China Regenerative Medicine International Limited Financial Overview
China Regenerative Medicine International Limited's market cap is currently HK$164.30M. The company's EPS TTM is HK$0.015; its P/E ratio is 29.67; China Regenerative Medicine International Limited is scheduled to report earnings on August 22, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
